Skip to main content

Table 3 Reported adverse events in both under-fives and children aged 5-10 years

From: Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania

Adverse event

Age groups

Total

Under-fives (n = 51)

Children aged ≥5 years (n = 28)

Cough

28(54.9%)

11(39.3%)

39(49.4%)

Fever

13(25.5%)

3(10.7%)

16(20.2%)

Abdominal pain

5(9.8%)

3(10.7%)

8(10.1%)

Diarrhoea

1(2.0%)

0(0%)

1(1.3%)

Headache

0(0%)

1(3.6%)

1(1.3%)

Skin rashes

1(2.0%)

0(0%)

1(1.3%)

None

3(5.9%)

10(35.7%)

13(16.5%)

Total

51(100%)

28(100%)

79(100%)